Among epithelial ovarian cancers (not benign tumors), which is the most common histological type encountered in clinical practice?

Explanation

## Most Common Epithelial Ovarian Carcinoma **Key Point:** Serous cystadenocarcinoma is the most common epithelial ovarian **carcinoma** (malignant tumor), accounting for ~40% of epithelial ovarian cancers. ### Distinction: Benign vs. Malignant Epithelial Tumors **High-Yield:** The question distinguishes between: - **Benign epithelial tumors** (cystadenomas) — most common is serous cystadenoma - **Malignant epithelial tumors** (carcinomas) — most common is serous cystadenocarcinoma ### Pathological Features of Serous Cystadenocarcinoma | Feature | Serous Cystadenoma | Serous Cystadenocarcinoma | | --- | --- | --- | | **Behavior** | Benign | Malignant | | **Architecture** | Simple cuboidal epithelium; smooth cyst wall | Complex glandular structures; papillary projections; stratification | | **Cellular atypia** | Absent | Present (nuclear enlargement, hyperchromasia, mitoses) | | **Invasion** | No stromal invasion | Invasion of ovarian stroma or beyond | | **Ascites** | Absent | Often present | | **CA-125** | Normal or mildly elevated | Markedly elevated | | **Prognosis** | Excellent (near 100% survival) | Variable (depends on stage) | ### Frequency of Epithelial Ovarian Carcinomas | Histotype | Frequency (%) | Grade | 5-Year Survival (%) | | --- | --- | --- | --- | | **Serous** | 40 | Often high-grade | 35–50 | | **Mucinous** | 10 | Often low-grade | 50–60 | | **Clear cell** | 10 | High-grade | 30–40 | | **Endometrioid** | 10 | Often low-grade | 50–70 | ### Clinical Pearl **Warning:** High-grade serous carcinoma (HGSC) is the most aggressive epithelial ovarian cancer subtype. It: - Often presents at advanced stage (III–IV) - Has TP53 mutations in >90% of cases - Responds to platinum-based chemotherapy initially but develops resistance - Has the worst prognosis among epithelial subtypes ### Why Serous Carcinoma Is Most Common 1. **Serous epithelium is abundant** — lines the entire ovarian surface and fallopian tubes 2. **Malignant transformation** — serous cystadenoma can undergo malignant transformation 3. **Molecular basis** — TP53 mutations drive high-grade serous carcinoma development [cite:Robbins 10e Ch 22]